PHILADELPHIA and VANCOUVER, British Columbia, April 23, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, ...

Paul Atkins, who was sworn in as the chairman of the Securities and Exchange Commission at the White House on Tuesday, said ...

Paul Atkins, who was nominated by President Donald Trump in what some say was a nod to the crypto industry, was sworn in ...

Paul Atkins, who previously served as a U.S. Securities and Exchange Commission member from 2002 to 2008 and was seen as a ...

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present two poster abstracts at the ...

Paul Atkins, President Trump’s pick to lead the Securities and Exchange Commission (SEC), will be sworn in Tuesday at a White ...

Three areas for investors to watch as Paul Atkins takes over as chair of the Securities and Exchange Commission.

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announce review of their January 2016 Research Collaboration and License Agreement (the "2016 Agreement") with ...

Zai Lab Limited today announced that updated data from an ongoing, global Phase 1a/1b clinical trial (NCT06179069) evaluating ZL-1310, the Company's potential first-in-class and best-in-class, ...

In an apparent social media blunder, the official White House Twitter account tagged a parody account in its announcement of ...

The abstracts will be available on the ASCO® website on May 22, 2025 at 5:00 p.m. ET. The full presentation will be available on the Merus website at the start of the session.